Jump Financial’s Pyxis Oncology PYXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-13,883
Closed -$46K 2035
2024
Q2
$46K Sell
13,883
-26,569
-66% -$112K ﹤0.01% 1694
2024
Q1
$172K Buy
+40,452
New +$170K ﹤0.01% 1718
2023
Q3
Sell
-31,026
Closed -$79.4K 2170
2023
Q2
$79.4K Buy
+31,026
New +$98.4K ﹤0.01% 1683

Other funds holding PYXS

Jump Financial's PYXS Position: Q3 2024 in Review

Jump Financial sold out of Pyxis Oncology (PYXS) in Q3 2024, closing a stake of 13,883 shares — an estimated $46K sold.

Jump Financial first reported a position in PYXS in Q2 2023 and held it in 3 quarters. The position peaked at $172K in Q1 2024. 92 funds tracked by Wall St. Rank hold PYXS as of Q3 2024.

  • Jump Financial reported no remaining Pyxis Oncology position as of Q3 2024 after selling out during the quarter.
  • Jump Financial sold 13,883 Pyxis Oncology shares in Q3 2024, an estimated $46K.
  • Jump Financial first reported a position in Pyxis Oncology in Q2 2023 and held it in 3 quarters.
  • Jump Financial's Pyxis Oncology position peaked at $172K in Q1 2024.
  • 92 funds tracked by Wall St. Rank held Pyxis Oncology as of Q3 2024.

Based on Jump Financial's 13F filing for Q3 2024, filed 14 Nov 2024.